<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>AI Survival Blog</title><link>https://aisurvival.blog/</link><description>Recent content on AI Survival Blog</description><generator>Hugo -- 0.155.3</generator><language>en-us</language><lastBuildDate>Wed, 18 Feb 2026 11:30:00 +0900</lastBuildDate><atom:link href="https://aisurvival.blog/index.xml" rel="self" type="application/rss+xml"/><item><title>About</title><link>https://aisurvival.blog/about/</link><pubDate>Wed, 18 Feb 2026 11:30:00 +0900</pubDate><guid>https://aisurvival.blog/about/</guid><description>&lt;h2 id="den-kim"&gt;Den Kim&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Head of Product at a proptech startup. Seoul-based.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;I&amp;rsquo;ve been investing in tech businesses for over 10 years, focusing on AI, semiconductors, and emerging technologies that reshape industries.&lt;/p&gt;
&lt;h3 id="why-this-blog"&gt;Why This Blog?&lt;/h3&gt;
&lt;p&gt;The AI revolution is creating both massive opportunities and existential risks for investors. I created AI Survival to help mid-level tech investors navigate this transformation with data-driven insights and practical strategies.&lt;/p&gt;
&lt;h3 id="what-youll-find-here"&gt;What You&amp;rsquo;ll Find Here&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Investment Insights&lt;/strong&gt;: Capturing lifestyle shifts driven by the AI era—from smarter living solutions to evolving consumer behaviors—and translating them into actionable investment strategies.&lt;/p&gt;</description></item><item><title>How AI is Killing Biotech: The AbCellera Collapse Reveals a Brutal Truth (Part 1)</title><link>https://aisurvival.blog/posts/ai-kills-biotech-axcellera-part1/</link><pubDate>Sun, 15 Feb 2026 17:30:00 +0900</pubDate><guid>https://aisurvival.blog/posts/ai-kills-biotech-axcellera-part1/</guid><description>AbCellera&amp;#39;s 92.6% decline exposes the structural disruption reshaping biotech. Why AI antibody discovery platforms are becoming obsolete.</description></item></channel></rss>